Barclays’s Elanco Animal Health ELAN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.4M | Sell |
267,582
-143,903
| -35% | -$3.52M | ﹤0.01% | 1674 |
|
|
2025
Q4 | $9.31M | Sell |
411,485
-317,809
| -44% | -$6.92M | ﹤0.01% | 1730 |
|
|
2025
Q3 | $14.7M | Buy |
729,294
+171,506
| +31% | +$2.87M | ﹤0.01% | 1401 |
|
|
2025
Q2 | $7.97M | Buy |
557,788
+283,290
| +103% | +$3.31M | ﹤0.01% | 1731 |
|
|
2025
Q1 | $2.88M | Sell |
274,498
-99,378
| -27% | -$1.12M | ﹤0.01% | 2355 |
|
|
2024
Q4 | $4.53M | Buy |
373,876
+161,972
| +76% | +$2.12M | ﹤0.01% | 2250 |
|
|
2024
Q3 | $3.11M | Buy |
211,904
+149,957
| +242% | +$2.09M | ﹤0.01% | 2487 |
|
|
2024
Q2 | $894K | Sell |
61,947
-281,712
| -82% | -$4.5M | ﹤0.01% | 2664 |
|
|
2024
Q1 | $5.59M | Sell |
343,659
-172,898
| -33% | -$2.7M | ﹤0.01% | 1773 |
|
|
2023
Q4 | $7.7M | Sell |
516,557
-1,012,577
| -66% | -$11.5M | ﹤0.01% | 1731 |
|
|
2023
Q3 | $17.2M | Buy |
1,529,134
+1,177,403
| +335% | +$13.7M | 0.01% | 802 |
|
|
2023
Q2 | $3.54M | Buy |
351,731
+69,155
| +24% | +$642K | ﹤0.01% | 1553 |
|
|
2023
Q1 | $2.66M | Sell |
282,576
-1,409,870
| -83% | -$16.6M | ﹤0.01% | 1976 |
|
|
2022
Q4 | $20.7M | Buy |
1,692,446
+1,309,792
| +342% | +$16.3M | 0.01% | 876 |
|
|
2022
Q3 | $4.75M | Buy |
382,654
+47,353
| +14% | +$828K | 0.01% | 1201 |
|
|
2022
Q2 | $6.58M | Buy |
335,301
+47,794
| +17% | +$1.13M | ﹤0.01% | 1198 |
|
|
2022
Q1 | $7.5M | Sell |
287,507
-385,026
| -57% | -$10.3M | 0.01% | 1027 |
|
|
2021
Q4 | $19.1M | Sell |
672,533
-236,980
| -26% | -$7.37M | 0.01% | 959 |
|
|
2021
Q3 | $29M | Buy |
909,513
+614,382
| +208% | +$20.6M | 0.01% | 743 |
|
|
2021
Q2 | $10.2M | Buy |
295,131
+10,098
| +4% | +$333K | ﹤0.01% | 1195 |
|
|
2021
Q1 | $8.39M | Sell |
285,033
-466,460
| -62% | -$14.3M | ﹤0.01% | 1165 |
|
|
2020
Q4 | $23M | Buy |
751,493
+146,943
| +24% | +$4.48M | 0.01% | 781 |
|
|
2020
Q3 | $16.9M | Buy |
604,550
+293,346
| +94% | +$7.43M | 0.01% | 816 |
|
|
2020
Q2 | $6.68M | Sell |
311,204
-101,003
| -25% | -$2.23M | 0.01% | 1178 |
|
|
2020
Q1 | $9.23M | Buy |
412,207
+216,158
| +110% | +$5.92M | 0.01% | 1033 |
|
|
2019
Q4 | $5.77M | Sell |
196,049
-189,829
| -49% | -$5.16M | ﹤0.01% | 1855 |
|
|
2019
Q3 | $10.3M | Sell |
385,878
-178,326
| -32% | -$5.35M | 0.01% | 1263 |
|
|
2019
Q2 | $19.1M | Buy |
564,204
+299,251
| +113% | +$9.72M | 0.01% | 960 |
|
|
2019
Q1 | $8.5M | Buy |
264,953
+258,300
| +3,882% | +$7.95M | 0.01% | 1323 |
|
|
2018
Q4 | $210K | Buy |
6,653
+6,553
| +6,553% | +$215K | ﹤0.01% | 4539 |
|
|
2018
Q3 | $3K | Buy |
+100
| New | +$3.52K | ﹤0.01% | 6880 |
|
Other funds holding ELAN
VPM
VCM
Barclays's ELAN Position: Q1 2026 in Review
Barclays reduced its Elanco Animal Health (ELAN) stake by 35% in Q1 2026, selling an estimated $3.52M and leaving 267,582 shares worth $6.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1674.
Barclays first reported a position in ELAN in Q3 2018 and has held it in 31 quarters since. The position peaked at $29M in Q3 2021. 516 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.
- Barclays held 267,582 shares of Elanco Animal Health worth $6.4M as of Q1 2026.
- Barclays sold 143,903 Elanco Animal Health shares in Q1 2026, an estimated $3.52M.
- Elanco Animal Health made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #1674 holding.
- Barclays first reported a position in Elanco Animal Health in Q3 2018 and has held it in 31 quarters since.
- Barclays's Elanco Animal Health position peaked at $29M in Q3 2021.
- 516 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.